Latest filing published 14 Mar 2022 for Chemomab Therapeutics Ltd., €4,663.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Nissim Darvish: trading record in brief
Nissim Darvish, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in 9 Meters Biopharma, Inc. and Chemomab Therapeutics Ltd. We count 3 filings; the first trade dates from 30 June 2020 and the latest from 11 March 2022.
On the market, this insider has only ever bought: 1 purchase, €4,663 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2022 to date brings 1 purchase and no sales.
Most recently, on 14 March 2022, the filings show an open-market purchase worth €4,663 in Chemomab Therapeutics Ltd. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nissim Darvish
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,200 shares@ US$4.28100.0% of flowAmerican Depositary SharesSEC:0001178913-22-001072:0Canonical exit: 9 Jun 2022 (T+90)
1 of 1 declaration
